Optima Medical Innovations Corp.
TOKIF · OTC
9/30/2021 | 6/30/2021 | 3/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $1,133 | $942 | $1,198 | -$1,338 |
| % Growth | 20.2% | -21.3% | 189.5% | – |
| Cost of Goods Sold | $1,109 | $972 | $1,427 | -$845 |
| Gross Profit | $23 | -$30 | -$229 | -$493 |
| % Margin | 2.1% | -3.2% | -19.1% | 36.8% |
| R&D Expenses | $0 | $0 | $0 | $33 |
| G&A Expenses | $339 | $137 | $569 | -$1,464 |
| SG&A Expenses | $195 | $137 | $171 | -$1,464 |
| Sales & Mktg Exp. | -$144 | $0 | -$397 | $0 |
| Other Operating Expenses | $0 | $62 | $0 | $391 |
| Operating Expenses | $195 | -$30 | $171 | -$1,297 |
| Operating Income | -$171 | -$0 | -$400 | $1 |
| % Margin | -15.1% | -0% | -33.4% | -0.1% |
| Other Income/Exp. Net | -$89 | $30 | $320 | -$865 |
| Pre-Tax Income | -$261 | $30 | -$78 | -$61 |
| Tax Expense | $0 | -$0 | $0 | $0 |
| Net Income | -$259 | $30 | -$78 | -$57 |
| % Margin | -22.9% | 3.2% | -6.5% | 4.3% |
| EPS | -0.005 | 0 | -0.002 | -1.13 |
| % Growth | -5,200% | 106.7% | 99.9% | – |
| EPS Diluted | -0.005 | 0 | -0.002 | -1.13 |
| Weighted Avg Shares Out | 50,648 | 50,648 | 50,648 | 50,576 |
| Weighted Avg Shares Out Dil | 50,648 | 50,648 | 50,648 | 50,575 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $204 | $0 | $0 |
| Interest Expense | $144 | $41 | $161 | $0 |
| Depreciation & Amortization | $134 | $139 | $137 | $197 |
| EBITDA | -$38 | $211 | $221 | $1,000 |
| % Margin | -3.3% | 22.3% | 18.5% | -74.7% |